NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/11/2025
Voltar para busca
Dado oficial do USPTO
DIVITUM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DIVITUM
ST13
US500000079344278Classe
1, 5, 42, 44
Pedido
79344278
Registro
7129071
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
23/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
13/04/2022
Data de registro
08/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/08/2023
Última transação
23/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
64
Localização do titular
SE
Examinador
LOZEAU,BRANDON THOMAS
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Biovica International AB
Representantes
Mark H. Tidman Baker & Hostetler LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use
Classe 5
Diagnostic agents and reagentspreparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagentspreparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases
Classe 42
Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapyin viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and developmentdiagnostic development; data science servicescompiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studiespreclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studiespreclinical studies regarding measurement of enzymatic activity
Classe 44
Medicalbiomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medicalbiomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medicalbiomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposesconducting tests to identify diseases affecting cell divisioncancerviral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancervirus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/12/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/11/2023
FIMP
FINAL DISPOSITION PROCESSED
13/11/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/11/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
GPNX
NOTIFICATION PROCESSED BY IB
24/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/05/2023
PUBO
PUBLISHED FOR OPPOSITION
23/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/04/2023
RFNT
REFUSAL PROCESSED BY IB
20/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/04/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/03/2023
RFRR
REFUSAL PROCESSED BY MPU
29/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2023
CNRT
NON-FINAL ACTION WRITTEN
02/02/2023
DOCK
ASSIGNED TO EXAMINER
31/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/10/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/10/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DIVITUM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.